eli lilly ceo on earnings and drug pricing
Published 5 years ago • 466 plays • Length 5:53Download video MP4
Download video MP3
Similar videos
-
6:32
eli lilly ceo: drug pricing bill would 'fundamentally restructure' company
-
6:05
eli lilly ceo david ricks on q2 results: seeing unbelievable demand for zepbound and mounjaro
-
6:43
eli lilly ceo on weight loss drugs outlook: our top priority is making more product
-
4:26
eli lilly ceo david ricks breaks down second-quarter earnings and drug pipeline
-
5:33
eli lilly ceo david ricks on 3-year obesity drug study: this is a profound result
-
6:11
leerink's david risinger talks eli lilly seeing best trading day in a year after earnings
-
30:33
eli lilly ceo dave ricks on revolutionizing healthcare and medicine
-
4:19
eli lilly is a 'great destination for investors', says deutsche bank's james shin after upgrade
-
2:37
eli lilly ceo: 'it's time for a change' in the drug pricing system
-
9:43
eli lilly ceo on quarterly earnings beat, pharma policy, and more
-
1:46
eli lilly releases new form of weight loss drug zepbound for half the price to boost access, supply
-
6:08
eli lilly ceo on slashing insulin prices, approval timelines for weight-loss and alzheimer's drugs
-
8:58
insulin pricing: eli lilly ceo | mad money | cnbc
-
4:29
eli lilly ceo david ricks breaks down q1 earnings, obesity drug trial results
-
7:33
watch cnbc's full interview with eli lilly ceo david ricks
-
4:12
eli lilly ceo: we're growing based on the back of our newest pharma products
-
5:50
eli lilly ceo: we expect to launch five new medicines in 2022
-
5:54
eli lilly ceo on 3q results, drug-pricing reforms
-
1:32
eli lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
-
4:05
vast utility for weight loss drugs will more than pay for themselves, says eli lilly ceo david ricks
-
3:39
eli lilly ceo david ricks on q1 earnings: this will be a year of both growth and investment
-
6:00
eli lilly's zepbound may be best-in-breed for weight loss drugs, says dr. kavita patel